HR 2426 requires the VA Secretary to commission an independent study comparing the quality of mental health and addiction care provided by VA health care providers versus non-VA providers for veterans. The study must examine health outcomes, use of proven treatment methods, care coordination, veteran satisfaction, and access times across different care types like telehealth and in-person visits. It mandates a report to Congress and public release within 18 months, detailing findings on factors like symptom improvement, suicide risk assessment, and whether veterans with multiple conditions receive integrated care. This bill directly affects veterans seeking mental health or addiction therapy services and aims to identify gaps in care quality between VA and non-VA systems.
This bill amends the 21st Century Cures Act to explicitly include fentanyl and xylazine test strips in grant funding for state and tribal programs addressing opioid use disorders. It directly affects state and tribal health agencies that receive federal grants under this program by expanding eligibility to cover these specific test strips. The key provision adds "fentanyl or xylazine test strips" to the list of approved items that grant funds may support, ensuring these critical tools for detecting dangerous substances are included in funding. The change updates existing grant language without creating new requirements or altering program administration.
The Overdose RADAR Act (S 690) provides federal grants to states, localities, and schools to improve opioid overdose response and data collection. It authorizes funding for better toxicology testing, data sharing across systems, and a wastewater pilot program to detect drugs like fentanyl in communities. The bill also creates new school-based grants allowing trained staff to administer naloxone for emergency opioid overdoses, requiring schools to maintain supplies and have certified personnel on-site. Additionally, it reforms the Office of National Drug Control Policy to coordinate national data standards and issue guidance on classifying non-self-induced overdoses as homicides.
The First Responders Wellness Act creates a national 24/7 mental health hotline for first responders (including police, firefighters, EMTs, and 911 dispatchers) and their families, offering toll-free voice and text support. The hotline must be staffed by trained peer specialists or mental health providers familiar with first responder stressors and must coordinate with existing crisis lines like 988. It requires annual public awareness campaigns, annual reports on effectiveness, and authorizes $10 million yearly for 2025-2031. The bill also directs a report on on-site crisis services for emergency response providers during major disasters.
This bill provides U.S. support to Ukraine for recovering children abducted by Russia and holding perpetrators accountable. It authorizes U.S. agencies to offer technical assistance - such as training in biometric identification, secure communications, and database management - to help Ukraine investigate abductions. The bill also funds medical, psychological, and educational services for returned children, along with legal aid for reintegration. Additionally, it supports Ukraine’s prosecution of abductors through U.S. advisory services and requires reports on U.S. assistance and coordination with international sanctions regimes.
HR 3595, the Safe Prescribing Through Reporting Act of 2025, requires healthcare providers to share certain records about prescribing or dispensing medications for substance use disorder with state prescription drug monitoring programs (PDMPs), but only when state law already mandates such reporting. This bill does not create new reporting requirements but ensures federal law aligns with existing state rules. It directly affects healthcare providers (like doctors and pharmacists) who prescribe or dispense medications for addiction treatment, as they must comply with their state's PDMP reporting rules. The key provision amends federal law to clarify that such disclosures are permissible under applicable state law.
S 1611 expands a federal grant program to fund research-based public service announcement (PSA) campaigns targeting youth substance use prevention. The bill adds a new grant category allowing funding for TV, radio, digital, and youth-submitted PSA contests using age-appropriate materials. Grantees (like schools or community groups) must report annually on campaign details, research used, regional messaging, alignment with other prevention efforts, and campaign effectiveness in reducing youth drug use. The Attorney General oversees this program and publishes annual reports on all funded campaigns.
The Fatal Overdose Reduction Act of 2025 establishes a Medicaid demonstration program to create "Health Engagement Hubs" that provide comprehensive, drop-in services for people with opioid use disorder and other substance use disorders. These hubs would offer harm reduction services, medication-assisted treatment, counseling, and social services like housing assistance and job training, with a focus on communities disproportionately impacted by overdose deaths. States would develop payment systems for these services, with up to 10 states selected to participate for 5 years, and would be required to report on outcomes like overdose rates and treatment access. The program would be funded through a $60 million planning grant and would require states to track demographic and health outcomes to assess effectiveness.
This bill reauthorizes a federal program supporting pregnant and postpartum women with substance use disorders. It increases annual funding from $29.9 million to $38.9 million for fiscal years 2025-2029, updates terminology to "health care services," and requires applicants to include outreach plans targeting women disproportionately impacted by maternal substance use disorder. The program directly affects eligible women seeking treatment during pregnancy and postpartum, ensuring continued access to care through expanded funding and targeted outreach. The changes apply to the existing Public Health Service Act program (Section 508) without altering its core purpose.
This bill requires the Veterans Health Administration to expand its existing informed consent directive (currently covering long-term opioid therapy) to include written consent for five additional medication categories: antipsychotics, stimulants, antidepressants, anxiolytics, and narcotics. It directly affects Veterans receiving VA care for these specific medications, mandating that providers obtain written informed consent before prescribing them. The key mechanism is updating VA Directive 1005 to explicitly apply to these new medication types, ensuring consistent consent processes across VA treatment. This change applies only to VA healthcare settings, not to civilian medical practices.
